Enbrel 50 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FUPQJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,974
Award facts
- Contract value 100% obligated
- $33,974.03 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $33,974.03 by the Defense Logistics Agency (DLA) on August 5, 2025, with an ultimate completion date of August 6, 2025. The delivery order, awarded under firm fixed-price terms with no set-aside designation, calls for the supply of Enbrel 50 mg/mL syringes. This award represents a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
The contract reflects AmerisourceBergen's critical role in the federal medical supply chain, particularly for military and veteran healthcare systems. As a competitively awarded contract, this delivery order demonstrates the company's capability to meet federal procurement requirements for specialized pharmaceutical products. The DLA Medical Supply Chain regularly issues such delivery orders to support the Defense Health Agency and other government healthcare systems, ensuring timely access to essential medications including immunosuppressants and biologics like Enbrel, which is commonly used in military medical treatment facilities for rheumatologic and autoimmune conditions.
Quick answers
Who was awarded contract SPE2DB25FUPQJ?
SPE2DB25FUPQJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 5, 2025.
How much is contract SPE2DB25FUPQJ worth?
The government has obligated $33,974 on SPE2DB25FUPQJ.
Is contract SPE2DB25FUPQJ an order under another contract?
Yes. SPE2DB25FUPQJ is a delivery order under SPE2DB25D3404, an indefinite delivery contract.
Was contract SPE2DB25FUPQJ competed?
The extent of competition for SPE2DB25FUPQJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award